SELLAS Life Sciences (SLS) Preferred Dividend Payments (2018 - 2020)
SELLAS Life Sciences (SLS) reported Preferred Dividend Payments of $78000.0 for Q1 2020, down 82.23% year-over-year from $439000.0 in Q2 2019, and up 132.1% quarter-over-quarter from -$243000.0 in Q4 2019.
SELLAS Life Sciences (SLS) Preferred Dividend Payments (2018 - 2020) Analysis & Trends
SELLAS Life Sciences (SLS) has 3 years of Preferred Dividend Payments data on file, last reported at $78000.0 in Q1 2020.
- Preferred Dividend Payments for Q1 2020 came in at $78000.0, down 82.23% year-over-year; the trailing twelve-month figure through Dec 2020 was $78000.0 (down 99.07% YoY), and the FY2020 annual result was $78000.0, down 99.07% from the prior year.
- Preferred Dividend Payments rose to $78000.0 in Q1 2020 per SLS's latest filing, from -$243000.0 in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $7.3 million in Q3 2019 and troughed at -$4.4 million in Q4 2018.
- A 3-year average of $814625.0 and a median of $465000.0 in 2018 frame the typical range for Preferred Dividend Payments.
- The sharpest annual moves came in 2019 and 2020: Preferred Dividend Payments surged 1380.24% in 2019, then slumped 82.23% in 2020.
- A 3-year view of Preferred Dividend Payments shows it stood at -$4.4 million in 2018, then soared by 94.52% to -$243000.0 in 2019, then soared by 132.1% to $78000.0 in 2020.
- Business Quant data shows SLS's Preferred Dividend Payments at $78000.0 in Q1 2020, -$243000.0 in Q4 2019, and $7.3 million in Q3 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 78,000.00 |
| Dec 31, 2019 | -243,000.00 |
| Sep 30, 2019 | 7.27 Mn |
| Jun 30, 2019 | 952,000.00 |
| Mar 31, 2019 | 439,000.00 |
| Dec 31, 2018 | -4.44 Mn |
| Sep 30, 2018 | 491,000.00 |
| Mar 31, 2018 | 1.97 Mn |